Chlorogenic acid alters the voltage-gated potassium channel currents of trigeminal ganglion neurons

Yu-Jiao Zhang , Xiao-Wen Lu , Ning Song , Liang Kou , Min-Ke Wu , Fei Liu , Hang Wang , Jie-Fei Shen

International Journal of Oral Science ›› 2014, Vol. 6 ›› Issue (4) : 233 -240.

PDF
International Journal of Oral Science ›› 2014, Vol. 6 ›› Issue (4) : 233 -240. DOI: 10.1038/ijos.2014.58
Article

Chlorogenic acid alters the voltage-gated potassium channel currents of trigeminal ganglion neurons

Author information +
History +
PDF

Abstract

A plant-derived compound with therapeutic potential may inhibit pain signals through its effects on specific nerve cell proteins. Scientists have recently begun exploring the anti-cancer, anti-inflammatory and neurological effects of chlorogenic acid (CGA), a molecule produced by bamboo and other plants. Jie-Fei Shen and colleagues at Sichuan University in China examined the effects of CGA on two ‘potassium-gated voltage channel’ (KV) proteins, which participate in nerve cell signaling. The researchers examined cells from the rat trigeminal ganglion, a nervous system structure that detects and responds to pain. CGA increased the activity of both KV proteins, and Shen and colleagues predict that the resulting response would gradually dampen trigeminal pain signaling. These findings could assist the development of drugs that block the severe discomfort associated with inflammatory and neuropathic pain.

Keywords

chlorogenic acid / trigeminal ganglion neuron / voltage-gated potassium channel / whole-cell patch clamp

Cite this article

Download citation ▾
Yu-Jiao Zhang, Xiao-Wen Lu, Ning Song, Liang Kou, Min-Ke Wu, Fei Liu, Hang Wang, Jie-Fei Shen. Chlorogenic acid alters the voltage-gated potassium channel currents of trigeminal ganglion neurons. International Journal of Oral Science, 2014, 6(4): 233-240 DOI:10.1038/ijos.2014.58

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

dos Santos MD, Almeida MC, Lopes NP. Evaluation of the anti-inflammatory, analgesic and antipyretic activities of the natural polyphenol chlorogenic acid. Biol Pharm Bull, 2006, 29(11): 2236-2240.

[2]

Bagdas D, Cinkilic N, Ozboluk HY. Antihyperalgesic activity of chlorogenic acid in experimental neuropathic pain. J Nat Med, 2013, 67(4): 698-704.

[3]

Feng R, Lu Y, Bowman LL. Inhibition of activator protein-1, NF-kappaB, and MAPKs and induction of phase 2 detoxifying enzyme activity by chlorogenic acid. J Biol Chem, 2005, 280(30): 27888-27895.

[4]

Kang TY, Yang HR, Zhang J. The studies of chlorogenic acid antitumor mechanism by gene chip detection: the immune pathway gene expression. J Anal Methods Chem, 2013, 2013: 617243.

[5]

Cinkilic N, Cetintas SK, Zorlu T. Radioprotection by two phenolic compounds: chlorogenic and quinic acid, on X-ray induced DNA damage in human blood lymphocytes in vitro. Food Chem Toxicol, 2013, 53: 359-363.

[6]

Shen W, Qi R, Zhang J. Chlorogenic acid inhibits LPS-induced microglial activation and improves survival of dopaminergic neurons. Brain Res Bull, 2012, 88(5): 487-494.

[7]

Ito H, Sun XL, Watanabe M. Chlorogenic acid and its metabolite m-coumaric acid evoke neurite outgrowth in hippocampal neuronal cells. Biosci Biotechnol Biochem, 2008, 72(3): 885-888.

[8]

Hach B, Heim F. [Comparative studieson the central stimulating effects of caffeie and chlorogenic acid in white mice.]. Arzneimittelforschung, 1971 German 23-25.

[9]

Ammon HP, Künkel H. [Significance of chlorogenic acid in the centrally-stimulating effect of coffee.]. Dtsch Med Wochenschr, 1976 German 460-464.

[10]

Oboh G, Agunloye OM, Akinyemi AJ. Comparative study on the inhibitory effect of caffeic and chlorogenic acids on key enzymes linked to Alzheimer's disease and some pro-oxidant induced oxidative stress in rats' brain-in vitro. Neurochem Res, 2013, 38(2): 413-419.

[11]

Shen JF, Chao YL, Du L. Effects of static magnetic fields on the voltage-gated potassium channel currents in trigeminal root ganglion neurons. Neurosci Lett, 2007, 415(2): 164-168.

[12]

Takeda M, Takahashi M, Matsumoto S. Inflammation enhanced brain-derived neurotrophic factor-induced suppression of the voltage-gated potassium currents in small-diameter trigeminal ganglion neurons projecting to the trigeminal nucleus interpolaris/caudalis transition zone. Neuroscience, 2014, 261: 223-231.

[13]

Takeda M, Tanimoto T, Ikeda M. Opioidergic modulation of excitability of rat trigeminal root ganglion neuron projections to the superficial layer of cervical dorsal horn. Neuroscience, 2004, 125(4): 995-1008.

[14]

Stewart T, Beyak MJ, Vanner S. Ileitis modulates potassium and sodium currents in guinea pig dorsal root ganglia sensory neurons. J Physiol Lond, 2003, 552(Pt 3): 797-807.

[15]

Pearce RJ, Duchen MR. Differential expression of membrane currents in dissociated mouse primary sensory neurons. Neuroscience, 1994, 63(4): 1041-1056.

[16]

Rasband MN, Park EW, Vanderah TW. Distinct potassium channels on pain-sensing neurons. Proc Natl Acad Sci U S A, 2001, 98(23): 13373-13378.

[17]

Piao L, Lee H, Li HY. Mechanosensitivity of voltage-gated K+ currents in rat trigeminal ganglion neurons. J Neurosci Res, 2006, 83(7): 1373-1380.

[18]

Takeda M, Tsuboi Y, Kitagawa J. Potassium channels as a potential therapeutic target for trigeminal neuropathic and inflammatory pain. Mol Pain, 2011, 7: 5.

[19]

Shen J, Wang H, Ma Y. [Effects of intracellular osmolality changes on the voltage-gated sodium channels currents of trigeminal ganglion neuron.]. Hua Xi Kou Qiang Yi Xue Za Zhi, 2012, 30(4): 338-342.

[20]

Hampson RE, Evans GJ, Mu J. Role of cyclic AMP dependent protein kinase in cannabinoid receptor modulation of potassium “A-current” in cultured rat hippocampal neurons. Life Sci, 1995, 56(23/24): 2081-2088.

[21]

Winkelman DL, Beck CL, Ypey DL. Inhibition of the A-type K+ channels of dorsal root ganglion neurons by the long-duration anesthetic butamben. J Pharmacol Exp Ther, 2005, 314(3): 1177-1186.

[22]

Takeda M, Tanimoto T, Ikeda M. Temporomandibular joint inflammation potentiates the excitability of trigeminal root ganglion neurons innervating the facial skin in rats. J Neurophysiol, 2005, 93(5): 2723-2738.

[23]

Takeda M, Tanimoto T, Nasu M. Temporomandibular joint inflammation decreases the voltage-gated K+ channel subtype 1.4-immunoreactivity of trigeminal ganglion neurons in rats. Eur J Pain, 2008, 12(2): 189-195.

[24]

Harriott AM, Dessem D, Gold MS. Inflammation increases the excitability of masseter muscle afferents. Neuroscience, 2006, 141(1): 433-442.

[25]

Takeda M, Kitagawa J, Nasu M. Glial cell line-derived neurotrophic factor acutely modulates the excitability of rat small-diameter trigeminal ganglion neurons innervating facial skin. Brain Behav Immun, 2010, 24(1): 72-82.

[26]

Takeda M, Takahashi M, Nasu M. Peripheral inflammation suppresses inward rectifying potassium currents of satellite glial cells in the trigeminal ganglia. Pain, 2011, 152(9): 2147-2156.

[27]

Takeda M, Kitagawa J, Takahashi M. Activation of interleukin-1beta receptor suppresses the voltage-gated potassium currents in the small-diameter trigeminal ganglion neurons following peripheral inflammation. Pain, 2008, 139(3): 594-602.

[28]

Liu CY, Li N, Zhao YF. [BK(Ca) channel agonist NS1619 and Kv channel antagonist 4-AP on the facial mechanical pain threshold in a rat model of chronic constriction injury of the infraorbital nerve.]. Sheng Li Xue Bao, 2010, 62(5): 441-449.

[29]

Everill B, Kocsis JD. Reduction in potassium currents in identified cutaneous afferent dorsal root ganglion neurons after axotomy. J Neurophysiol, 1999, 82(2): 700-708.

[30]

Birinyi-Strachan LC, Gunning SJ, Lewis RJ. Block of voltage-gated potassium channels by Pacific ciguatoxin-1 contributes to increased neuronal excitability in rat sensory neurons. Toxicol Appl Pharmacol, 2005, 204(2): 175-186.

[31]

Harriott AM, Gold MS. Contribution of primary afferent channels to neuropathic pain. Curr Pain Headache Rep, 2009, 13(3): 197-207.

[32]

Farah A, Monteiro M, Donangelo CM. Chlorogenic acids from green coffee extract are highly bioavailable in humans. J Nutr, 2008, 138(12): 2309-2315.

[33]

Amor S, Puentes F, Baker D. Inflammation in neurodegenerative diseases. Immunology, 2010, 129(2): 154-169.

[34]

Block ML, Zecca L, Hong JS. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci, 2007, 8(1): 57-69.

[35]

Block ML, Hong JS. Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism. Prog Neurobiol, 2005, 76(2): 77-98.

[36]

Chauhan PS, Satti NK, Sharma P. Differential effects of chlorogenic acid on various immunological parameters relevant to rheumatoid arthritis. Phytother Res, 2012, 26(8): 1156-1165.

[37]

Jaffrey SR, Erdjument-Bromage H, Ferris CD. Protein S-nitrosylation: a physiological signal for neuronal nitric oxide. Nat Cell Biol, 2001, 3(2): 193-197.

[38]

Ahern GP, Klyachko VA, Jackson MB. cGMP and S-nitrosylation: two routes for modulation of neuronal excitability by NO. Trends Neurosci, 2002, 25(10): 510-517.

[39]

Jiang N, Shi P, Desland F. Interleukin-10 inhibits angiotensin II-induced decrease in neuronal potassium current. Am J Physiol Cell Physiol, 2013, 304(8): C801-C807.

[40]

Czeschik JC, Hagenacker T, Schäfers M. TNF-alpha differentially modulates ion channels of nociceptive neurons. Neurosci Lett, 2008, 434(3): 293-298.

AI Summary AI Mindmap
PDF

121

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/